Bellicum Pharmaceuticals Announces Rivo-cel™ Achieves Primary Endpoint in Pediatric Registrational Trial

NEXT STORY
ADMA Biologics Receives FDA Approval for License Transfers for BIVIGAM® and Nabi-HB®
PREV STORY
Progenics Pharmaceuticals Strengthens Management Team with Appointment of Huw Jones as Vice President, Commercial
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Genocea’s GEN-009 Clinical Results Presentation Selected by ASCO’s Journal of Clinical Oncology® as a Top 10 Featured Immuno-oncology Abstract

author_avatar
NASDAQ Market News

Vaxil Announces Non-Brokered Private Placement

author_avatar
NASDAQ Market News

Worldwide Aminoglycosides Markets, 2019 to 2024: Expiry of Patent Exclusivity has Led to Large Scale Generic Manufacturing of Aminoglycosides, Particularly in the Developing Region of Asia-Pacific

author_avatar
NASDAQ Market News